Abbonarsi

Diagnostic and treatment algorithm for chronic nodular prurigo - 09/01/20

Doi : 10.1016/j.jaad.2019.07.022 
Hartmut F. Ständer, MD a, Sarina Elmariah, MD, PhD b, Claudia Zeidler, MD c, Mary Spellman, MD d, Sonja Ständer, MD c,
a Dermatological Practice, Bad Bentheim, Department of Dermatology, Klinikum Dortmund gGmbH, Dortmund, Germany 
b Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts 
c Center for Chronic Pruritus, Department of Dermatology, University Hospital Münster, Münster, Germany 
d Menlo Therapeutics Inc, Redwood City, California 

Correspondence to: Sonja Ständer, MD, Center for Chronic Pruritus, Department of Dermatology, University Hospital Münster, Von-Esmarch-Strasse 58, 48149 Münster, Germany.Center for Chronic PruritusDepartment of DermatologyUniversity Hospital MünsterVon-Esmarch-Strasse 58Münster48149Germany

Abstract

Chronic nodular prurigo (CNPG) is a subtype of chronic prurigo, also called prurigo nodularis, and a chronic skin condition characterized by intensely pruritic nodular lesions. Although the exact cause of CNPG is unknown, it appears to result from a repetitive itch-scratch cycle induced by neuronal sensitization to chronic pruritus. CNPG is associated with an underlying dermatologic condition in about half of patients, and it can also be attributed to systemic, neurologic, psychogenic, or unknown causes. For most patients, multiple underlying causes are identified. Patients with CNPG often experience impaired quality of life, sleep disturbance, anxiety, and depression. To encourage consistent and accurate diagnosis and treatment of CNPG across regions, we are proposing a diagnostic and treatment algorithm that includes initial assessment of core symptoms, detailed dermatologic history and clinical examination, patient-reported outcomes, diagnostic workup, and recommended therapies. This information is supplemented with photographs to illustrate clinical appearance and disease severity. Because CNPG is often multifactorial and it can take months to years for lesions to heal, interdisciplinary cooperation and long-term management are important.

Il testo completo di questo articolo è disponibile in PDF.

Key words : algorithm, chronic nodular prurigo, diagnosis, prurigo nodularis, prurigo scoring, prurigo severity, treatment

Abbreviations used : CNPG, DLQI, IL, NK1R, NRS, VAS


Mappa


 Funding sources: Supported by Menlo Therapeutics Inc.
 Disclosure: Dr HF Ständer is a member of scientific advisory boards and is a consultant for Menlo Therapeutics, Leo, Novartis, and Sanofi-Aventis. Dr Elmariah serves as a scientific advisor to Menlo Therapeutics, AOBiome, and Trevi Therapeutics. Dr Spellman was employed by Menlo Therapeutics Inc. Dr. S Ständer is a principal investigator for Dermasence, Galderma, Kiniksa, Menlo Therapeutics, Trevi Therapeutics, Novartis, and Vanda and is a member of scientific advisory boards and a consultant for Almirall, Astellas, Beiersdorf, Celgene, Galderma, Kiniksa, Kneipp, Maruho, Menlo Therapeutics, NeRRe Therapeutics, Novartis, Sanofi, Sienna, and Trevi Therapeutics. Dr Zeidler has no conflict of interest to declare.


© 2019  American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 82 - N° 2

P. 460-468 - febbraio 2020 Ritorno al numero
Articolo precedente Articolo precedente
  • Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review
  • Franchesca D. Choi, Christina N. Kraus, Ashley N. Elsensohn, Sama K. Carley, Larisa M. Lehmer, Rebecca T. Nguyen, Kenneth G. Linden, Jessica Shiu
| Articolo seguente Articolo seguente
  • The long-term clinical consequences of juvenile vulvar lichen sclerosus: A systematic review
  • Beth Morrel, Rachel van Eersel, Curt W. Burger, Wichor M. Bramer, Marianne J. ten Kate-Booij, Irene A.M. van der Avoort, Suzanne G.M.A. Pasmans

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.